GB1209326A - The preparation of 3-methyl-5-pyrazole carboxylic acid amides - Google Patents

The preparation of 3-methyl-5-pyrazole carboxylic acid amides

Info

Publication number
GB1209326A
GB1209326A GB42957/67A GB4295767A GB1209326A GB 1209326 A GB1209326 A GB 1209326A GB 42957/67 A GB42957/67 A GB 42957/67A GB 4295767 A GB4295767 A GB 4295767A GB 1209326 A GB1209326 A GB 1209326A
Authority
GB
United Kingdom
Prior art keywords
methyl
acid amides
amine
sept
ammonia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB42957/67A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharmaceuticals Inc
Original Assignee
Carter Wallace Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carter Wallace Inc filed Critical Carter Wallace Inc
Publication of GB1209326A publication Critical patent/GB1209326A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Abstract

1,209,326. 3-Methyl-5-pyrazolecarboxylic acid amides. CARTER WALLACE Inc. 21 Sept., 1967 [27 Sept., 1966], No. 42957/67. Heading C2C. [Also in Division A5] 3 - Methyl - 5 - pyrazolecarboxylic acid amides of the formula wherein R is NH 2 or a radical of a substituted o<SP>r</SP> unsubstituted primary or secondary amine (the compounds in which R in the above formula represents morpholino, piperidono, benzylamino and p-chlorobenzylamino being novel) are prepared by treating ethyl acetopyruvate, dissolved in glacial acetic acid, with hydrazine hydrate, cooling to cause ethyl 3-methyl-5- pyrazole carboxylate to precipitate, reacting said ester with ammonia or primary or secondary amine in stoichiometrically equivalent proportions in an aqueous alcoholic solution, in an excess of the amine, or in aqueous solution containing an excess of the amine or ammonia, flreuxing for 4 to 15 hours and collecting the precipitated amide. Reference has been directed by the Comptroller to Specification 1,048,104.
GB42957/67A 1966-09-27 1967-09-21 The preparation of 3-methyl-5-pyrazole carboxylic acid amides Expired GB1209326A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2213566A IT1053661B (en) 1966-09-27 1966-09-27 AMID OF ACID 3 5 METHYL 5 3 PYRAZOL CARBOXYLIC

Publications (1)

Publication Number Publication Date
GB1209326A true GB1209326A (en) 1970-10-21

Family

ID=11192002

Family Applications (1)

Application Number Title Priority Date Filing Date
GB42957/67A Expired GB1209326A (en) 1966-09-27 1967-09-21 The preparation of 3-methyl-5-pyrazole carboxylic acid amides

Country Status (9)

Country Link
BE (1) BE704290A (en)
CH (1) CH479588A (en)
DE (1) DE1670466A1 (en)
ES (1) ES345849A1 (en)
FR (1) FR7254M (en)
GB (1) GB1209326A (en)
IT (1) IT1053661B (en)
NL (1) NL6713145A (en)
SE (1) SE333147B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077909A1 (en) * 2004-02-17 2005-08-25 Laboratorios Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
EP1637522A1 (en) * 2004-09-16 2006-03-22 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
EP1743889A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
EP1746090A1 (en) * 2005-07-15 2007-01-24 Laboratorios del Dr. Esteve S.A. Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
WO2007009702A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
WO2007009706A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
EP1950202A1 (en) * 2007-01-24 2008-07-30 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments with ACAT inhibition activity
US7524868B2 (en) 2004-02-17 2009-04-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7659408B2 (en) * 2003-08-07 2010-02-09 Merck Sharp & Dhome Corp. Pyrazole carboxamides as inhibitors of 11-β-hydroxysteroid dehydrogenase-1
US7897589B2 (en) 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7968582B2 (en) 2005-07-15 2011-06-28 Laborotorios Del Dr. Esteve, S.A. 5(S)-substituted pyrazoline compounds, their preparation and use as medicaments
US7994200B2 (en) 2005-07-15 2011-08-09 Laboratorios Del Dr. Esteve, S.A. Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
US7998996B2 (en) 2004-02-17 2011-08-16 Laboratorios Del Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659408B2 (en) * 2003-08-07 2010-02-09 Merck Sharp & Dhome Corp. Pyrazole carboxamides as inhibitors of 11-β-hydroxysteroid dehydrogenase-1
JP2007522252A (en) * 2004-02-17 2007-08-09 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ Substituted pyrazoline compounds, their preparation and their use as pharmaceuticals
US7998996B2 (en) 2004-02-17 2011-08-16 Laboratorios Del Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
WO2005077909A1 (en) * 2004-02-17 2005-08-25 Laboratorios Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
US7524868B2 (en) 2004-02-17 2009-04-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1637522A1 (en) * 2004-09-16 2006-03-22 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
WO2007009702A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
WO2007009706A3 (en) * 2005-07-15 2007-04-19 Esteve Labor Dr Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
WO2007009702A3 (en) * 2005-07-15 2007-04-05 Esteve Labor Dr Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
WO2007009706A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
EP1746090A1 (en) * 2005-07-15 2007-01-24 Laboratorios del Dr. Esteve S.A. Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
US7897589B2 (en) 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7968582B2 (en) 2005-07-15 2011-06-28 Laborotorios Del Dr. Esteve, S.A. 5(S)-substituted pyrazoline compounds, their preparation and use as medicaments
US7994200B2 (en) 2005-07-15 2011-08-09 Laboratorios Del Dr. Esteve, S.A. Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
EP1743889A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
US8106085B2 (en) 2005-07-15 2012-01-31 Laboratorios Del Dr. Esteve, S.A. Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
US8207156B2 (en) 2005-07-15 2012-06-26 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1950202A1 (en) * 2007-01-24 2008-07-30 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments with ACAT inhibition activity

Also Published As

Publication number Publication date
NL6713145A (en) 1968-03-28
CH479588A (en) 1969-10-15
SE333147B (en) 1971-03-08
DE1670466A1 (en) 1972-01-27
FR7254M (en) 1969-09-08
ES345849A1 (en) 1968-11-16
IT1053661B (en) 1981-10-10
BE704290A (en) 1968-02-01

Similar Documents

Publication Publication Date Title
GB1209326A (en) The preparation of 3-methyl-5-pyrazole carboxylic acid amides
GB1180749A (en) A New Polycyclic Amine and Processes for its Production
ES466857A1 (en) 4-Hydroxy pyrrolidin-2-onyl-amides
GB1334705A (en) Pharmaceutical compositions containing kynurenic acid derivatives
GB1235869A (en) 2-methyl-3-carbamoylquinoxaline-1,4-dioxides
GB1154260A (en) N-Aromatically Substituted Acid Amides
GB1312391A (en) Basically substituted 4 3h- quinazolinone derivatives and process for their manufacture
GB1210810A (en) Novel n-substituted anilines and processes for their preparation
GB1225714A (en)
GB1136933A (en) Process for the production of tetra--‡-substituted anthraquinone derivatives
ES293930A1 (en) Preparation of 6-aminoacylpenicillanic acids
GB1159493A (en) Metal Chelates
SE321485B (en)
GB1240817A (en) Herbicidal agents
GB1181406A (en) N-Dialkylaminoalkyl p-(2-Alkoxy-Benzoyl)-Aminobenzoates and their Quaternary Ammonium Salts and Processes for their Preparation
GB1219848A (en) NOVEL N-SUBSTITUTED-o-PHENYLENE AMINES, AND PROCESSES FOR THEIR PREPARATION
GB1205094A (en) Improvements in or relating to the treatment of hypertension
GB1053429A (en)
GB1235761A (en) Carboxylic acid (1,2,4-thiadiazolyl-5)-amides
GB1192248A (en) A process for the preparation of Novel Diphenylamine Derivatives
GB1170856A (en) A process for the production of alpha-Amino-alpha-Methyl-propionanilide Derivatives
ES273163A1 (en) Dibenzodiazepinone derivatives
GB1217623A (en) Acrylonitrile copolymers
ES311820A1 (en) Procedure for the production of indollic derivatives. (Machine-translation by Google Translate, not legally binding)
GB1191592A (en) Preparation of Indolylacetic Acids and Novel Intermediates used in it

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees